Northrop Grumman Corp (NOC) stock
NOCNYSESearch, Detection, Navigation, Guidance, Aeronautical SysFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 18/3014% below fair value
$557.54−4.82 (-0.86%)
Close on Oct 30, 2026Market cap $79.21BP/E 17.7Yield 1.61%
Earnings
Northrop Grumman's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Jan 26, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$11.10B
+6.7% on a year earlier
Adjusted EPS, Q3 FY2026
$7.89
$7.67 a year earlier
Latest guidance
Issued
Oct 20, 2026 · 4 items
Quarterly results
Revenue and earnings per share from each of Northrop Grumman's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 26, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 20, 2026before the open | $11.10B | +6.7% | $7.89 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 21, 2026before the open | $10.90B | +4.8% | $7.68 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026before the open | $9.90B | +4.6% | $6.14 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 27, 2026before the open | $11.70B | +9.3% | $9.99 | $7.23 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 21, 2025before the open | $10.40B | +4.0% | $7.67 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 22, 2025before the open | $10.40B | +2.0% | $8.15 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 22, 2025before the open | $9.47B | -6.3% | $3.32 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 30, 2025before the open | $10.70B | +0.9% | $8.66 | $6.39 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 24, 2024before the open | $10.00B | +2.0% | $7.00 | $7.00 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $10.20B | +6.3% | $6.36 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024before the open | $10.10B | +8.6% | $6.32 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 25, 2024before the open | $10.60B | +6.0% | -$3.54 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $9.80B | +8.9% | $6.18 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023before the open | $9.60B | +9.1% | $5.34 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023before the open | $9.30B | +5.7% | $5.50 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 26, 2023before the open | $10.00B | +16.3% | $13.46 | $7.50 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $9.00B | +3.4% | $5.89 | $5.89 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 28, 2022before the open | $8.80B | – | $6.06 | $6.06 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $8.80B | – | $6.10 | $6.10 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 27, 2022before the open | $8.60B | – | $17.14 | $6.00 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $8.70B | – | $6.63 | $6.63 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 28, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 22, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Northrop Grumman's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| SalesGAAP | FY2026 | $43.75B – $44.25B | – | New | Oct 20, 2026 |
| Sales | FY2026 | $43.50B – $44.00B | $43.50B – $44.00B | Reaffirmed | Apr 21, 2026 |
| Segment operating incomenon-GAAP | FY2026 | $4.94B – $5.04B | – | New | Oct 20, 2026 |
| Segment operating incomenon-GAAP | FY2026 | $4.85B – $5.00B | $4.85B – $5.00B | Reaffirmed | Jul 21, 2026 |
| MTM-adjusted EPSnon-GAAP | FY2026 | $29.35 – $29.75 | – | New | Oct 20, 2026 |
| MTM-adjusted EPSnon-GAAP | FY2026 | $28.60 – $29.10 | $27.40 – $27.90 | Raised | Jul 21, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $3.10B – $3.50B | – | New | Oct 20, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $3.10B – $3.50B | $3.10B – $3.50B | Reaffirmed | Jul 21, 2026 |
Guidance vs results
The last range Northrop Grumman gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $41.70B – $41.90B | $41.97BΣ4Q | Above range |
Guidance history
Every forecast Northrop Grumman put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 20, 2026 | MTM-adjusted EPS | FY2026 | $29.35 – $29.75 | New |
| Oct 20, 2026 | Adjusted free cash flow | FY2026 | $3.10B – $3.50B | New |
| Oct 20, 2026 | Segment operating income | FY2026 | $4.94B – $5.04B | New |
| Oct 20, 2026 | Sales | FY2026 | $43.75B – $44.25B | New |
| Jul 21, 2026 | MTM-adjusted EPS | FY2026 | $28.60 – $29.10 | Raised |
| Jul 21, 2026 | Adjusted free cash flow | FY2026 | $3.10B – $3.50B | Reaffirmed |
| Jul 21, 2026 | Segment operating income | FY2026 | $4.85B – $5.00B | Reaffirmed |
| Apr 21, 2026 | MTM-adjusted EPS | FY2026 | $27.40 – $27.90 | Reaffirmed |
| Apr 21, 2026 | Free cash flow | FY2026 | $3.10B – $3.50B | Reaffirmed |
| Apr 21, 2026 | Segment operating income | FY2026 | $4.85B – $5.00B | Reaffirmed |
| Apr 21, 2026 | Sales | FY2026 | $43.50B – $44.00B | Reaffirmed |
| Jan 27, 2026 | MTM-adjusted EPS | FY2026 | $27.40 – $27.90 | New |
| Jan 27, 2026 | Free cash flow | FY2026 | $3.10B – $3.50B | New |
| Jan 27, 2026 | Segment operating income | FY2026 | $4.85B – $5.00B | New |
| Jan 27, 2026 | Sales | FY2026 | $43.50B – $44.00B | New |
| Oct 21, 2025 | MTM-adjusted EPS | FY2025 | $25.65 – $26.05 | Raised |
| Oct 21, 2025 | Free cash flow | FY2025 | $3.05B – $3.35B | Reaffirmed |
| Oct 21, 2025 | Segment operating income | FY2025 | $4.28B – $4.38B | Reaffirmed |
| Oct 21, 2025 | Sales | FY2025 | $41.70B – $41.90B | New |
| Jul 22, 2025 | MTM-adjusted EPS | FY2025 | $25.00 – $25.40 | New |
| Jul 22, 2025 | Free cash flow | FY2025 | $3.05B – $3.35B | New |
| Jul 22, 2025 | Segment operating income | FY2025 | $4.28B – $4.38B | New |
| Jul 22, 2025 | Sales | FY2025 | $42.05B – $42.25B | New |
| Apr 22, 2025 | MTM-adjusted EPS 1 | FY2025 | $24.95 – $25.35 | Lowered |
| Apr 22, 2025 | Free cash flow 1 | FY2025 | $2.85B – $3.25B | Reaffirmed |
| Apr 22, 2025 | Segment operating income 1 | FY2025 | $4.20B – $4.35B | Lowered |
| Apr 22, 2025 | Sales | FY2025 | $42.00B – $42.50B | Reaffirmed |
| Jan 30, 2025 | MTM-adjusted EPS | FY2025 | $27.85 – $28.25 | New |
| Jan 30, 2025 | Free cash flow | FY2025 | $2.85B – $3.25B | New |
| Jan 30, 2025 | Segment operating income | FY2025 | $4.65B – $4.80B | New |
| Jan 30, 2025 | Sales | FY2025 | $42.00B – $42.50B | New |
| Oct 24, 2024 | MTM-adjusted EPS | FY2024 | $25.65 – $26.05 | Raised |
| Oct 24, 2024 | Free cash flow | FY2024 | $2.25B – $2.65B | Reaffirmed |
| Oct 24, 2024 | Segment operating income | FY2024 | $4.53B – $4.58B | Raised |
| Oct 24, 2024 | Sales | FY2024 | $41.00B – $41.40B | New |
| Jul 25, 2024 | Capital expenditures | FY2024 | $1.80B | New |
| Jul 25, 2024 | MTM-adjusted EPS | FY2024 | $24.90 – $25.30 | Raised |
| Jul 25, 2024 | Free cash flow | FY2024 | $2.25B – $2.65B | Reaffirmed |
| Jul 25, 2024 | Operating income | FY2024 | $4.28B – $4.36B | Raised |
| Jul 25, 2024 | Segment operating income | FY2024 | $4.50B – $4.58B | Raised |
| Jul 25, 2024 | sales | FY2024 | $41.00B – $41.40B | New |
| Apr 25, 2024 | Capital expenditures | FY2024 | $1.80B | Reaffirmed |
| Apr 25, 2024 | MTM-adjusted EPS | FY2024 | $24.45 – $24.85 | Reaffirmed |
| Apr 25, 2024 | Free cash flow | FY2024 | $2.25B – $2.65B | Reaffirmed |
| Apr 25, 2024 | Operating income | FY2024 | $4.22B – $4.29B | Reaffirmed |
| Apr 25, 2024 | Segment operating income | FY2024 | $4.48B – $4.55B | Reaffirmed |
| Apr 25, 2024 | Sales | FY2024 | $40.80B – $41.20B | Reaffirmed |
| Jan 25, 2024 | Capital expenditures | FY2024 | $1.80B | New |
| Jan 25, 2024 | MTM-adjusted EPS | FY2024 | $24.45 – $24.85 | New |
| Jan 25, 2024 | Free cash flow | FY2024 | $2.25B – $2.65B | New |
| Jan 25, 2024 | Operating income | FY2024 | $4.22B – $4.29B | New |
| Jan 25, 2024 | Segment operating income | FY2024 | $4.48B – $4.55B | New |
| Jan 25, 2024 | Sales | FY2024 | $40.80B – $41.20B | New |
| Oct 26, 2023 | Capital expenditures | FY2023 | $1.65B – $1.70B | Reaffirmed |
| Oct 26, 2023 | MTM-adjusted EPS | FY2023 | $22.45 – $22.85 | Reaffirmed |
| Oct 26, 2023 | Adjusted free cash flow | FY2023 | $1.85B – $2.15B | Reaffirmed |
| Oct 26, 2023 | Operating income | FY2023 | $3.95B – $4.05B | Reaffirmed |
| Oct 26, 2023 | Segment operating income | FY2023 | $4.30B – $4.40B | Reaffirmed |
| Oct 26, 2023 | Sales | FY2023 | $39.00B | Raised |
| Jul 27, 2023 | Capital expenditures | FY2023 | $1.65B – $1.70B | Reaffirmed |
| Jul 27, 2023 | MTM-adjusted EPS | FY2023 | $22.45 – $22.85 | Raised |
| Jul 27, 2023 | Adjusted free cash flow | FY2023 | $1.85B – $2.15B | Reaffirmed |
| Jul 27, 2023 | Operating income | FY2023 | $3.95B – $4.05B | Reaffirmed |
| Jul 27, 2023 | Segment operating income | FY2023 | $4.30B – $4.40B | Reaffirmed |
| Jul 27, 2023 | Sales | FY2023 | $38.40B – $38.80B | Raised |
| Apr 27, 2023 | Capital expenditures | FY2023 | $1.65B – $1.70B | Reaffirmed |
| Apr 27, 2023 | MTM-adjusted EPS | FY2023 | $22.25 – $22.85 | Raised |
| Apr 27, 2023 | Adjusted free cash flow | FY2023 | $1.85B – $2.15B | Reaffirmed |
| Apr 27, 2023 | Operating income | FY2023 | $3.95B – $4.05B | Reaffirmed |
| Apr 27, 2023 | Segment operating income | FY2023 | $4.30B – $4.40B | Reaffirmed |
| Apr 27, 2023 | Sales | FY2023 | $38.00B – $38.40B | Reaffirmed |
| Jan 26, 2023 | Capital expenditures | FY2023 | $1.65B – $1.70B | New |
| Jan 26, 2023 | MTM-adjusted EPS | FY2023 | $21.85 – $22.45 | New |
| Jan 26, 2023 | Adjusted Free cash flow | FY2023 | $1.85B – $2.15B | New |
| Jan 26, 2023 | Operating income | FY2023 | $3.95B – $4.05B | New |
| Jan 26, 2023 | Segment operating income | FY2023 | $4.30B – $4.40B | New |
| Jan 26, 2023 | Sales | FY2023 | $38.00B – $38.40B | New |
| Oct 27, 2022 | diluted earnings per share | FY2022 | $24.50 – $25.10 | Reaffirmed |
| Oct 27, 2022 | transaction-adjusted free cash flow | FY2022 | $1.50B – $1.80B | Reaffirmed |
| Oct 27, 2022 | Operating margin % | FY2022 | 9.8% – 10% | Reaffirmed |
| Oct 27, 2022 | Segment operating margin % | FY2022 | 11.7% – 11.9% | Reaffirmed |
| Oct 27, 2022 | sales | FY2022 | $36.20B – $36.60B | New |
| Jul 28, 2022 | Transaction-adjusted EPS | FY2022 | $24.50 – $25.10 | Reaffirmed |
| Jul 28, 2022 | Transaction-adjusted free cash flow based on current tax law | FY2022 | $1.50B – $1.80B | Reaffirmed |
| Jul 28, 2022 | Operating margin % | FY2022 | 9.8% – 10% | Reaffirmed |
| Jul 28, 2022 | Segment operating margin % | FY2022 | 11.7% – 11.9% | Reaffirmed |
| Jul 28, 2022 | Intangible asset amortization & PP&E step-up depreciation | FY2022 | $240.00M | Lowered |
| Jul 28, 2022 | Weighted average diluted shares outstanding | FY2022 | 155 | New |
| Jul 28, 2022 | Total net FAS/CAS pension adjustment | FY2022 | $1.31B | Reaffirmed |
| Jul 28, 2022 | Other items | FY2022 | $210.00M | Lowered |
| Jul 28, 2022 | Interest expense | FY2022 | $530.00M | Raised |
| Jul 28, 2022 | Effective tax rate % | FY2022 | 17% | New |
| Jul 28, 2022 | Sales | FY2022 | $36.20B – $36.60B | Reaffirmed |
| Apr 28, 2022 | Transaction-adjusted EPS | FY2022 | $24.50 – $25.10 | Reaffirmed |
| Apr 28, 2022 | Transaction-adjusted free cash flow assuming section 174 tax deferral | FY2022 | $2.50B – $2.80B | Reaffirmed |
| Apr 28, 2022 | Transaction-adjusted free cash flow based on current tax law | FY2022 | $1.50B – $1.80B | Lowered |
| Apr 28, 2022 | Operating margin % | FY2022 | 9.8% – 10% | Reaffirmed |
| Apr 28, 2022 | Segment operating margin % | FY2022 | 11.7% – 11.9% | Reaffirmed |
| Apr 28, 2022 | Weighted average diluted shares outstanding | FY2022 | 155 | New |
| Apr 28, 2022 | Effective tax rate % | FY2022 | 17% | New |
| Apr 28, 2022 | Total net FAS/CAS pension adjustment | FY2022 | $1.31B | New |
| Apr 28, 2022 | Intangible asset amortization & PP&E step-up depreciation | FY2022 | $240.00M | New |
| Apr 28, 2022 | Other items | FY2022 | $270.00M | Raised |
| Apr 28, 2022 | Interest expense | FY2022 | $540.00M | Raised |
| Apr 28, 2022 | Sales | FY2022 | $36.20B – $36.60B | Reaffirmed |
| Jan 27, 2022 | Transaction-adjusted EPS | FY2022 | $24.50 – $25.10 | New |
| Jan 27, 2022 | Transaction-adjusted free cash flow 1 assuming section 174 tax deferral | FY2022 | $2.50B – $2.80B | New |
| Jan 27, 2022 | Operating margin % | FY2022 | 9.8% – 10% | New |
| Jan 27, 2022 | Segment operating margin % | FY2022 | 11.7% – 11.9% | New |
| Jan 27, 2022 | Organic Sales | FY2022 | +2% – +3% | New |
| Jan 27, 2022 | Sales | FY2022 | $36.20B – $36.60B | New |
| Oct 28, 2021 | Transaction-adjusted EPS | FY2021 | $25.20 – $25.60 | New |
| Oct 28, 2021 | Transaction-adjusted free cash flow | FY2021 | $3.00B – $3.30B | New |
| Oct 28, 2021 | Operating margin % | FY2021 | 16% – 16.2% | New |
| Oct 28, 2021 | Segment operating margin % | FY2021 | 11.7% – 11.9% | New |
| Oct 28, 2021 | Sales | FY2021 | $36.00B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Northrop Grumman filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Results